\
&
Contact us
\
&
Contact us
Starts in 1 month from now
LocationMellieħa (Malta)
The European Conference on EDGE AI Technologies and Applications (EEAI) gathers representatives from academia, researchers, and industry practitioners to exchange the latest advances in the state of the art and practice of edge AI technologies and applications, identify emerging research topics, and define the future of edge AI research and innovation. Its scope covers the edge AI technology stack, following emerging research and innovation from hardware to software, edge AI frameworks, generative AI, agentic AI, architectures, algorithms, data types and methods, to applications.
More information on the programme can be found on the event website.
Please note that this is a paying event.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
